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CytokinesImmune responses during infection with pandemic H1N1 2009 inﬂuenza A virus (2009-H1N1) are still
poorly understood. Using an experimental infection model in ferrets, we examined the pathological features
and characterized the host immune responses by using microarray analysis, during infection with 2009-
H1N1 A/California/07/2009 and seasonal A/Brisbane/59/2007. Chemokines CCL2, CCL8, CXCL7 and CXCL10
along with the majority of interferon-stimulated genes were expressed early, correlated to lung pathology,
and abruptly decreased expression on day 7 following infection of A/California/07/2009. Interestingly, the
drop in innate immune gene expression was replaced by a signiﬁcant increase of the adaptive immune genes
for granzymes and immunoglobulins. Serum anti-inﬂuenza antibodies were ﬁrst observed on day 7,
commensurate with the viral clearance. We propose that lung pathology in humans occurs during the innate
phase of host immunity and a delay or failure to switch to the adaptive phase may contribute to morbidity
and mortality during severe 2009-H1N1 infections.rnational Institute of Infection
ge, Xingling Road. 22, 515045
).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.In the springof 2009, human transmissionof anew inﬂuenzaA strain
was reported in the United States andMexico (2009a,b,c,d; Cameron et
al., 2009; Chowell et al., 2009; Dawood et al., 2009; Perez-Padilla et al.,
2009; Shinde et al., 2009), within a fewweeks it spread to other regions
of the globe and the World Health Organization raised the pandemic
alert phase to “level 6, of moderate severity” (http://www.who.it/
inﬂuenza/AH1N1/20090611_11). By the end of November, worldwide
more than 207 countries and overseas territories had reported
laboratory conﬁrmed cases of pandemic H1N1 2009 inﬂuenza A virus
(2009-H1N1), including over 7820 deaths (http://www.who.int/csr/
don/2009_11_27a/en/index.html). This inﬂuenza virus is a triple-
reassortment ofmultiple strains of inﬂuenza A viruses circulating in the
domestic swine population (Smith et al., 2009). While the vast majority
of human cases appear to be self limiting and resolve within 2 weeks of
onset of symptoms, a small number of infections lead to severe
respiratory illness. Symptoms include fever and cough and possiblesore throat, diarrhea and vomiting. In a minority of cases, 6–10 days
following onset of symptoms, severe lower respiratory complications
arisewith radiographic abnormalities.Hospitalization and ventilation in
these casesmay be required. Fatal cases, while extremely rare, are most
often associated with underlying medical conditions that contribute to
illness severity. Interestingly, histological examination of a lung
specimen from a severe case of 2009-H1N1 showed necrotizing
bronchiolitis with alveolar damage and hyaline formation (Perez-
Padilla et al., 2009). This ﬁnding is similar to histopathological ﬁndings
in human inﬂuenza-infected lung specimens from previous pandemics
(Taubenberger and Morens, 2008).
The antigenic nature of 2009-H1N1 is distinct from seasonal
human A (H1N1) viruses such as A/Brisbane/59/2007, but is similar
to circulating North American swine A (H1N1) viruses (Garten et al.,
2009). The antigenic dissimilarity between 2009-H1N1 and seasonal
H1N1 viruses suggests that the general population has little or no
preexisting immunity to 2009-H1N1. This notion is reinforced since
some seasonally vaccinated individuals develop classic inﬂuenza
symptoms and illness caused by 2009-H1N1 infection. In the absence
of preexisting immunity in the general population, the modest
mortality and morbidity associated with the majority of human
2009-H1N1 infections are puzzling. The paucity of information
258 T. Rowe et al. / Virology 401 (2010) 257–265regarding host immune responses to 2009-H1N1 and the role they
play in controlling the viral infection led us to investigate the
evolution of innate and adaptive host immune responses following
2009-H1N1 exposure.
To better understand the natural history of 2009-H1N1 infection and
underlying immunological, clinical, pathological andmolecular features
of disease course, we infected twenty-nine ferrets with 106 50% egg
infectious doses of the 2009-H1N1 vaccine strain, A/California/07/
2009, and observed for clinical signs, changes in body temperature and
weight on a daily basis. Additionally we looked for viral replication in
respiratory tissue, pathology, host innate and adaptive immune
responses and changes in gene expression. The study was completed
with data obtained from ferrets infected with seasonal H1N1 inﬂuenza
A/Brisbane/59/2007, which provided additional insight in a disease
that displays different clinical presentations.
Results
Pathological features of the infection with A/California/07/2009 in
ferrets
Following the challenge with California/07, ferrets exhibited
classical clinical signs of inﬂuenza infection including elevated
temperature, weight loss, nasal discharge, sneeze (Table 1 and
Supplementary Fig. 1) and crusty nose (22% of ferrets on day 6 PI).
Animals lost weight throughout the ﬁrst week post challenge and
slowly recovered by day 14 PI. 3 ferrets on day 6 PI and 2 ferrets on
day 7 PI, lost more than 20% of their initial weight and they were
euthanized. The resulting mortality rate was 27%. Viral kinetics
demonstrated early replication in the upper tract at day 1 PI, which
decreased over the following 4 days (Fig. 1A). Viral load was low on
day 1 in the trachea and progressively increased until day 5 PI
(Fig. 1B). Viral titers in lung tissue showed great variability, it was
initially detected on day 1 and peaked on day 5 PI (Fig. 1C). No virus
was detected in any airway tissues on day 7 or later (Fig. 1).
Hemagglutining inhibition assay (HAI) in serum samples revealed
the early presence of hemagglutinin inhibiting A/California/07 (HAI)
antibodies as soon as day 7 PI (Fig. 5C). This is mostly an IgM response
with IgG following at later times (data not shown).
The lungs of California/07 infected ferrets had severe and rapid
histopathological changes (Figs. 1D and 2A–L). Early in infection,
atelectasis was widespread with intra-alveolar exudate varying from
mild to severe (Figs. 2A–C). Bronchial epithelium showed moderate
intracellular edema with occasional supra-epithelial exudate containing
acute inﬂammatory cells (Figs. 2E–F). At day 1 post infection,marginating
leukocytes invaded the vascular walls and the intense inﬂammatory
inﬁltration over the ensuing week led to vascular adventitial destruction
(Fig. 2K). Early bronchial epithelial necrosis was observed focally on dayTable 1
Clinical observations and viral load in ferrets infected with inﬂuenza A/Brisbane/59/2007
Clinical signs
Lethalitya Inactivityb % weight lossc (day)
Seasonal (H1N1) 0% 1.1 5% (D7)
A/Brisbane/59/07
2009-H1N1 27% 1.4 16% (D6)
A/California/07/09
a N20% weight loss from prechallenged (D0) weight.
b Relative inactivity index (D1–D6) post challenge.
c Day post challenge of peak weight loss from prechallenged weight.
d Average elevated temperatures above baseline °C and (days post challenge elevated).
e Average viral load.
f Baseline=1.8 log10.1, was widespread by days 2 and 3, peaked between days 3 and 5 and
was relatively quiescent by day 7 PI (Figs. 2D–G and I–K). Bronchial
submucosal glands also had acute inﬂammation thatwasmaximal by day
3, but persisted for 1–2 weeks (data not shown). At twoweeks PI, chronic
inﬂammation was mostly restricted to submucosal regions (data not
shown). Intra-alveolar exudate and hemorrhage was pervasive by days
3–5 andwere replaced by cellular consolidationwith hyperplasia of type-
II pneumocytes between days 5 and 7. At one-week PI, central lung
regions were more consolidated while peripheral alveoli contained
exudate and inﬂammatory cells. Gram stain of the tissue did not reveal
any organisms in the lung at any time after infection.
Beginning at day 1 post infection, immunocytochemistry showed
inﬂuenza viral antigens predominantly along the apical surfaces of
bronchi and bronchial submucosal glandular epithelium (Figs. 2J–L).
Immunocytochemical staining is pronounced at day 1, peaked at day 3
and rapidly declined by days 5 and 7 (data not shown). Viral infection
was associated with epithelial necrosis and sloughing into the
airways. This process was sufﬁciently rapid and severe that many
airways were obstructed by necrotic plugs debris (Fig. 2L). Immuno-
cytochemical staining of gut, lymphoid tissue, pancreas, and brain
demonstrated no evidence of viral antigens or inﬂammatory lesions
(data not shown).
Pathological features of the infection with A/Brisbane/59/2007
Ferrets infected with Brisbane/59 displayed mild clinical symp-
toms such as 5% maximum weight loss, nasal discharge, sneeze and
protracted fever, and without lethality (Table 1 and Supplementary
Fig. 1). The virus was detected in the nasal wash of infected ferrets and
the viral load peaked on day 3 post infection. Hemagglutinin
inhibiting A/Brisbane/57 antibodies were detected in serum samples
on day 7 PI, and higher titers on day 14 PI were found (Fig. 5C).
Histological assessment in the nasal turbinates displayed inﬂamma-
tory inﬁltrate on days 2 and 5 post infection, with sloughing in some
areas (data not shown). In the lung tissue of Brisbane/59 infected
ferrets, the viral load was found to be below detection levels (Table 1,
Figs. 1A and C) and no histological abnormalities were found (Fig. 1E).
Gene expression proﬁles in lung tissue of infected animals
To determine the temporal relationship between host immune
responses and the progression and resolution of 2009-H1N1 clinical
disease, we conducted a longitudinal study of expression patterns of
host immune genes in the lungs of infected animals using high density
microarrays (Figs. 3A and 4A–B). On day three post infection, there
was a signiﬁcant increase in interferon-stimulated genes (ISG)
(Fig. 3A), a functional group that included numerous genes for
antiviral proteins (e.g. OAS1 and 2) and transcriptional regulators (e.g.and A/California/07/2009.
Peak viral loade
(Log10)TCID50/g or ml
Elevated temperatured (days) Tissue Peak (day)
1.9 °C (D2) Nasal wash 3.0±0.3 (D2)
Trachea Not done
Lung b1.8f
1.1 °C–1.3 °C Nasal wash 5.0±1.2 (D1)
(D2–D5) Trachea 4.6±0.9 (D5)
Lung 5.1±2.5 (D5)
Fig. 1. Viral replication of inﬂuenza A/California/07/2009 and A/Brisbane/59 in ferrets following intranasal challenge. (A) Nasal wash, (B) trachea and (C) lungs were collected from
ferrets at indicated days post infection and titered on MDCK cells (TCID50). Hematoxylin and eosin stained sections from parafﬁn embedded lung tissue: (D) A/California/07/2009,
(E) A/Brisbane/59/2007 and (F) uninfected.
259T. Rowe et al. / Virology 401 (2010) 257–265STAT1) (Malmgaard, 2004). In contrast to the robust expression
pattern observed for 2009-H1N1, lungs from animals infected with
seasonal H1N1 Brisbane/59 expressed a restricted pattern of ISGs. On
day 5, only 12 ISGs were upregulated (mean expression levels were at
least 1.5-fold respect to the control group), while lungs from ferrets
infected with California/07 displayed 26 upregulated ISGs. Concom-
itant with early expression of ISGs, California/07 induced the
expression of multiple chemokines including CCL2, CCL8, CCL13,
CCL19, CXCL7 and CXCL10, and also inﬂammatory cytokines such as
TNFα and IL-1β (Figs. 4A and 5A). These mediators participate in the
recruitment of multiple leukocyte subsets including NK cells,
monocyte/macrophages, T cells and granulocytes (Charo and Ransoh-
off, 2006). We observed that their expression patterns coincided with
the inﬁltration of inﬂammatory mononuclear cells and polymorpho-
nuclear leukocytes in the lungs during infection with California/07
(Figs. 2A–L). Lungs from Brisbane/59-infected animals showed
involvement of a limited number of cytokine/chemokines (Fig. 4A)
and lower expression levels compared with California/07 (Fig. 5A).
The modest lung response during the infection with Brisbane/59, in
terms of ISGs, cytokines and chemokines, is likely due to a lack of local
host immune activation as the lungs had no detectable viral load
(Table 1). In the lungs of California/07-infected ferrets, a striking
decrease in the expression of ISGs and the chemokines CCL2, CCL8,
and CXCL10 takes place on day 7 (Figs. 3A, 4A and 5A). Clinically, on
day seven, animals reached the nadir of weight loss and began a slow,
but progressive increase, in weight. In contrast to the reduction in ISG
and chemokine expression on day seven, expression of genes
associated with the effector phase of adaptive immunity (e.g. Ig
lambda, CD3, granzyme A, granzyme B, and granzyme H) is increased
in 2009-H1N1 infected lungs (Fig. 4B). Similarly, increased expression
of granzymes A, B, and H is also observed in peripheral blood on day 7
(Fig. 5B). The shift from innate to adaptive immune responses is
further supported by the appearance of hemagglutinin inhibiting
serum antibodies on day 7 (Fig. 5C).Discussion
Here, we have used the ferret model of inﬂuenza infection as a
surrogate for understanding 2009-H1N1 induced pathogenesis and
the evolution of host immune responses. Infected ferrets display a
number of pathological alterations, such as increased temperature,
sneezing, loss of bodyweight and histological features consistent with
virally induced pneumonia, an experimental model that mimics 2009-
H1N1 human disease. The results from our study and those from
recently published papers, show that the severity can range from a
sublethal infection with mild symptoms when using A/California/04/
2009 (Itoh et al., 2009; Maines et al., 2009) and A/Netherlands/602/
2009 (Munster et al., 2009) inﬂuenza strains, to 30% lethality found in
our study with California/07, or 50% lethality with A/Mexico/4482/
2009 (Maines et al., 2009). All these viral strains infected both the
lower and upper respiratory tracts in ferrets. On the contrary, our
results and others (Maines et al., 2009), show that seasonal H1N1
Brisbane/59 causes mild illness in ferrets and only affects the upper
respiratory tract. While our pathological ﬁndings are in keeping with
the ﬁndings of other authors, our unique immunological data allows
for the ability to model host immune responses and pathological
changes to 2009-H1N1 over the course of illness.
As expected, increased levels of ISGs appeared early in the course of
the viral infection, these genes are usually stimulated by the type I
interferon signaling pathway (Fig. 3B) (Malmgaard, 2004) and
disruption of this pathway in mice leads to uncontrolled viral infection
and death (Durbin et al., 2000). It is well established that the
relationship between high levels of proinﬂammatory mediators and
degree of lung pathology (de Jong et al., 2006), however the
contribution of other factors, such as the direct cytopatic effect caused
by the virus, still needs to be assessed. The progressive increase in
weight and overall health of animals between days 7 and 14, and the
elimination of viral load in respiratory tissues by day 7, indicate that
adaptive immunemechanismswere responsible for resolution of 2009-
Fig. 2. Histopathology of upper and lower respiratory tract of inﬂuenza-infected tissues. Low power overview of lungs from days 2 (A), 3 (B) and 5 (C) post infection showing
progressive atelectasis with inﬂamed bronchi and alveoli ﬁlled with acute hemorrhage progressing to intense panlobular pneumonia with bronchial plugs and alveolar
consolidation. (D) Day 7: bronchial lumen with necrotic tissue plugs, adjacent blood vessels with adventitial clearing, surrounding alveoli with inﬂammatory exudates. (E) Day 2:
acutely necrotic bronchus. (F) Day 3: inﬂamed bronchial submucosal glands. (G) Day 7: bronchial lumen with necrotic tissue plugs. (H) Day 7: nasal turbinates with inﬂamed
submucosal glands. (I) Day 1: infection of bronchial epithelium and submucosal glands. (J) Day 1: infection of tracheal epithelium and submucosal glands. (K) Day 1: infection of
bronchial epithelium and submucosal glands. (L) Day 1: infection of bronchial epithelium with sloughing. Panels A through H—hematoxylin and eosin stained parafﬁn embedded
sections, panels I through L—anti-inﬂuenza immunohistochemistry on parafﬁn embedded sections.
260 T. Rowe et al. / Virology 401 (2010) 257–265H1N1 induced disease. Infection with Brisbane/59 also produced the
early production of neutralizing antibodies and granzymes on day 7,
however it is possible that the virus had already been cleared by the
innate response (Brisbane/59 is below detection levels on day 3) by the
time when the adaptive response was triggered in naïve ferrets.
The global analysis of our data support the idea that the host
immune responses were biphasic in nature, with an early robust
innate ISG and chemokine response that shut down as an adaptive
immune phase was initiated (Fig. 6). The timing of the “switch”
between these two phasesmay be important for eliminating viral load
and orchestrating the reduction of inﬂammation associated with early
stages of disease. A failure to effectively switch from innate to
adaptive responses may be, in part, responsible for severe cases of
2009-H1N1 that result in hospitalization and in some cases death.
Gene expression of some ISGs, chemokines CCL2, CCL8, and
CXCL10, and the inﬂammatory cytokines TNFα and IL-1β appear to
be related to the pathological phase of 2009-H1N1.Moreover, levels of
CXCL10 and CCL2 correlate well with respiratory illness severity and
they have been associatedwith human severe cases of SARS and H5N1
infections (Cameron et al., 2007; de Jong et al., 2006), therefore
CXCL10 and CCL2 may be useful bio-markers for human disease
severity. It will be important to determine if underlying medical
conditions associated with severe 2009-H1N1 disease cause aberrant
or delayed innate-adaptive immune switching leading to severe
inﬂuenza H1N1 disease.Materials and methods
Infection and monitoring of ferrets
Animal experiments with virus A/California/07/2009 and with A/
Brisbane/59/2007 were performed in the AAALAC-accredited ABSL-3
facility, University of Pittsburgh and in the ABSL-2 enhanced facility
Animal Resource Centre, University Health Network, Toronto, respec-
tively. All procedures were conducted in accordance with the NRC
Guide for the Care and Use of Laboratory Animals, the Animal Welfare
Act, and the CDC-NIH Biosafety in Microbiological and Biomedical
Laboratories and approved by the Institutional Animal Care and Use
Committee. All ferrets were proven seronegative by HI assay against
A/California/04/2009, A/Brisbane/59/2007 and B/Florida/04/2006.
Castrated, descented male ﬁtch ferrets (Mustela putorius furo), 5–
9 months of age and weighing between 800 and 1500 g (Triple F
Farms Inc., Sayre, PA, USA) were pair-housed in individually HEPA-
ﬁltered biocontainment caging (Allentown Inc., Allentown, NJ, USA).
Ferrets were given food and water ad libitum. Animals were infected
and monitored as previously described (Zitzow et al., 2002), except
using 5% isoﬂuorane anesthesia. Brieﬂy, 29 male ﬁtch ferrets were
anesthetized with isoﬂuorane and infected intranasally with 1×106
50% egg infectious doses (EID50) (∼1×105.75 TCID50/ml) of A/
California/07/2009 in a volume of 1 ml. From these, four animals
were sacriﬁced on days 1, 3, 5, 7, and 14 days post infection (PI). Nasal
Fig. 3. Interferon responses in ferret lung tissue. A) Hierarchical gene clustering of interferon-stimulated genes (ISGs) during infection with inﬂuenza A/California/07/2009 and A/Brisbane/59/2007. B) Pathway modeling of the interferon
responses in the lungs of ferrets infected with inﬂuenza A/California/07/2009 using the gene expression data on day 5 post infection (red, upregulated).
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Fig. 4. Gene expression levels in ferrets during infection with inﬂuenza A/California/07/2009 and A/Brisbane/59/2007. Hierarchical gene clustering of different functional
categories in lung tissue, A) cytokine/chemokines and B) leukocyte markers.
262 T. Rowe et al. / Virology 401 (2010) 257–265washes, lung tissue and blood samples were collected from each ferret
in order to determine viral load, gross and histopathological ﬁndings,
innate and adaptive host immune responses, and molecular changes
associated with disease course. The remaining nine animals were
allowed to go to endpoint. A/California/07/2009 is the World Health
Organization recommended isolate for generation of 2009-H1N1
vaccines (http://www.who.int/entity/csr/resources/publications/
swineﬂu/H1N1Vaccinevirusrecommendation26May2009.pdf) and
was thus the virus used for ferret studies. An additional 4 ferrets
were used as day 0 uninfected controls. Temperatures were measured
through the use of an implantable temperature transponder (BMDS,
Sayre, PA) and were recorded daily at approximately the same time
each day. Pre-infection values were averaged to obtain a baseline
temperature for each ferret. The change in temperature was
calculated daily for each animal. Weight loss and clinical signs of
sneezing and nasal discharge, other respiratory distress, and level of
activity were assessed daily. A scoring system was used to assess
activity level where 0 = alert and playful; 1 = alert but playful only
when stimulated; 2 = alert but not playful when stimulated; and 3=
neither alert nor playful when stimulated. Based on the daily scores
for each animal in a group, a relative inactivity index was calculated
(Zitzow et al., 2002).Fig. 5. RT-PCR quantitation of differentially expressed genes from ferrets infected with A/Cal
observed in the H1N1 microarray dataset, we compared the levels of CCL2, CXCL10, IL-1β an
days 2 (Brisbane/59 only), 3 (California/07 only), 5, 7 and 14 post infection. B) Quantitation
the amount of endogenous β-actin transcript. *pb0.05, **pb0.01. C) Serum anti-inﬂuenza aAn additional 15 ferrets were infected with 1×106 EID50 of A/
Brisbane/59/2007 and monitored for clinical signs. On days 1, 2, 5, 7
and 14 post infection, 3 ferrets were euthanized and organs collected
for pathological examination, virus titration and microarray analysis.
A group of 3 uninfected controls was also included.
Histopathology
Lung tissue excised from the middle lobes was formalin-ﬁxed and
parafﬁn embedded. Tissue slides were stained with hematoxylin/
eosin for histopathologic assessment. Immunostain was performed by
using a polyclonal goat anti-inﬂuenza A 1:500 (#PAB7123P, Maine
Biotechnology Services, Portland, ME, USA) followed by incubation
with a donkey anti-goat b/c antibody 1:200 (#805-7602, Rockland
immunochemical, Gilbertsville, PA, USA).
Determination of viral load
MDCK cells plated in 6-well tissue culture plates were inoculated
with 0.1 ml of virus serially diluted in Dulbecco's modiﬁed Eagle's
medium (DMEM). Virus was adsorbed to cells for 1 h, with shaking
every 15 min. Wells were overlaid with 1.6% w/v Bacto agar (DIFCO,ifornia/07/2009 and A/Brisbane/59/2007. A) To validate the expressionmeasurements
d TNFα RNA in lung tissue from infected ferrets with uninfected ferret controls during
of mRNA levels of granzymes A, B and H in blood samples. Data shown is normalized to
ntibodies measured by HI (geometric mean titers).
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Fig. 6. Stylized representation of biphasic host immune response against 2009-H1N1
inﬂuenza A. Phase I is characterized by increases in interferon response genes (ISG),
chemokines and proinﬂammatory cytokines (green line) that drive lung pathology. A
cellular/molecular switch causes a transition from innate to adaptive immunity,
signaling a shut down in ISGs and chemokines and an increase in effector adaptive
genes and molecules (red line) and a decrease in viral load (dashed line).
264 T. Rowe et al. / Virology 401 (2010) 257–265BD Diagnostic Systems, Palo Alto, CA, USA)mixed 1:1 with L-15media
(Cambrex, East Rutherford, NJ, USA) containing antibiotics and
0.6 µg/ml TPCK–trypsin (Sigma, St. Louis, MO, USA). Plates were
inverted and incubated for 4 days. Cells were ﬁxed for 10 min using
70% v/v ethanol and then overlaid with 1% w/v crystal violet. Cells
were then washed with deionized water to visualize plaques. Plaques
were counted and compared to uninfected cells. Additionally, viral
load was assessed by HA activity in tissues which were homogenized
10% w/v in DMEM and serially diluted (1/2 log) from 10–0.5 to 10–6.5
in quadruplicate on MDCK cells. After 2 h incubation at 37 °C, 5% CO2
samples were removed and replaced with DMEM containing 1% BSA,
1 µg/ml TPCK–trypsin and antibiotics and incubated. On day 6 post
infection, 50 µl of supernatant were tested for presence of virus by HA
activity against 0.5% turkey erythrocytes. The viral loads were
determined as the reciprocal of the dilution resulting in 50% HA
positivity. Titers are given as TCID50 per gram of tissue or TCID50/ml
for nasal washes.
Hemagglutinin inhibition (HI) assay
RDE-treated sera were serially diluted in v-bottom 96-well
microtiter plates followed by the addition of 4 hemagglutination
units (HAU) of inﬂuenza virus. Following an incubation of approxi-
mately 15 min, 0.5% turkey erythrocytes (TRBC) were added and
mixed by agitation. The TRBC were allowed to settle for 30 min at
room temperature and HI titers were determined by the reciprocal
value of the last dilution of sera which inhibited hemagglutination of
TRBC by the virus. A negative titer was calculated as 10.
RNA extraction and microarray analysis
RNA extraction and microarray analysis were performed as
previously published (Cameron et al., 2008) except for the gene
classiﬁcation methods. Brieﬂy, lung sections (∼1 g) were obtained
during necropsy and immediately put in RNAlater (Ambion, Austin,
TX, USA) then homogenized in TriPure reagent, and total RNA was
isolated according to the manufacturer's recommended protocol
(Roche, Indianapolis, IN, USA). Total RNA was ampliﬁed using
MessageAMP kits (Ambion). cRNA (10 µg) was labeled and hybrid-ized to Affymetrix GeneChip Canine Genome 2.0 Array (Affymetrix,
Santa Clara, CA, USA). Probe-level analysis was performed using the
Probe Logarithmic Intensity Error Estimate (PLIER) method in
Expression Console Version 1.1 (Affymetrix). The raw intensity values
for each target on the Affymetrix arrays were preprocessed with
variance stabilization, log2 transformation, and normalization to the
control group (day 0 samples) excluding elements withmedian signal
intensities of b6 log2 units across samples. Time series analysis was
performed using EDGE version 1.1.291 (Storey et al., 2005) with
Q≤0.005. DAVID bioinformatic tool (Huang da et al., 2009) was used
to perform functional classiﬁcation in differentially expressed genes,
using a biological signiﬁcance ﬁlter of ≥1.5-fold, and additional
custom enrichment of functional categories (ISGs, cytokine/chemo-
kines and leukocyte markers) was performed. Gene hierarchical
clustering and heat map generation was done using the Multi
Experiment Viewer 4.4 software (Saeed et al., 2006). Ingenuity
Pathway Analysis 7.6 (IPA) (Ingenuity Systems, Redwood City, CA,
USA)was used to select, annotate, and visualize genes by function and
pathway. Datasets are publicly available at the NCBI's Gene Expression
Omnibus.(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE17079).
qRT-PCR
Quantitative real-time PCR (qRT-PCR) was performed in triplicate
using an ABI-Prism 7900 HT (Applied Biosystems, Foster City, CA,
USA). PCR reactions were performed in a 10 µl reaction volume using
SYBR green master mix (Applied Biosystems), 40 ampliﬁcation cycles
and the annealing temperature was 60°. Primer sequences were as
follows: for CCL2, 5′-GCTCCCTATTCACTTGCTGTTTC-3′ (forward) and
5′-GATTCGATAGCCCTCCAGCTT-3′ (reverse); for CXCL10, 5′-
CTTTGAACCAAAGTGCTGTTCTTATC-3′ (forward) and 5′-AGCGTG-
TAGTTCTAGAGAGAGGTACTC-3′ (reverse); for IL-1β, 5′-GGACTG-
CAAATTCCAGGACATAA-3′ and 5′-TTGGTTCACACTAGTTCCGTTGA-3′
(reverse); and for TNFα, 5′-CCAGATGGCCTCCAACTAATCA-3′ (for-
ward) and 5′-GGCTTGTCACTTGGAGTTCGA-3′ (reverse). Expression
levels were normalized using the house-keeping gene β-actin and
results were expressed as arbitrary units. The statistical analysis was
performed using the SPSS 16.0 software (SPSS Inc., Chicago, IL, USA)
and the Student's t test was used to assess the statistical differences in
the expression levels in respect to the control groups.
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